Aldosterone synthase inhibitors for treating chronic kidney disease

TW202633608APending Publication Date: 2026-08-16BOEHRINGER INGELHEIM INT GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW115115086
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2021-12-14
Filing Date: 2022-12-13
Publication Date: 2026-08-16

Application Information

Patent Timeline

14 Dec 2021

Priority

13 Dec 2022

Application

TW115115086

16 Aug 2026

Publication

TW202633608A

IPC: A61K31/435; A61K31/34; A61K31/35; A61K31/41; A61K31/4188; A61P3/10; A61P13/12

Inventors: 寇寧麗莎 V; 哈斯奇西比樂珍妮

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to treatment of chronic kidney disease by administering to patients in need thereof a compound of formula (I): , and pharmaceutically acceptable salts thereof, wherein Cy, R1and R2 are as defined herein. The invention further relates to the use of the compounds of formula (I) in combination with sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Need to check novelty before this filing date? Find Prior Art